In May 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders in Lisbon on best practices in transitioning from a function that supports scientific communication and manages relationships with thought leaders to a function that is a strategic leader at the center of clinical development and commercialization efforts.
The group touched upon how a Medical Affairs function could be structured and supported to be set up for success, how it needs to be integrated with commercial and R&D, and how the added value should be measured and communicated. Finally, we discussed the merits of a stepwise evolution in a company’s Medical Affairs function.
In this summary, we will elaborate upon the thoughts brought up during the Roundtable, highlighting the key topics including foundational elements for Medical Affairs’ success, full integration of Medical Affairs across the business, and measuring the added value and becoming champions.
This summary was also published at Medical Affairs Professional Society.
